Source link : https://www.newshealth.biz/health-news/fda-grants-mirvetuximab-full-approval-for-ovarian-cancer/
The US Food and Drug Administration granted full approval to mirvetuximab soravtansine-gynx (Elahere) for adults with folate receptor alpha–positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received one to three prior systemic treatment regimens. AbbVie noted in a press release that its antibody-drug conjugate is the first treatment to show a […]
Author : News Health
Publish date : 2024-03-25 11:49:33
Copyright for syndicated content belongs to the linked Source.
Categories